12:00 AM
 | 
Jul 14, 2003
 |  BioCentury  |  Product Development

dSLIMming the immune system

The immune system normally doesn't recognize antigens associated with cancer as "other," which has made developing cancer vaccines difficult. Mologen AG thinks its dSLIM adjuvant may act as an immune modulator that sensitizes the immune system to antigens that it would normally overlook.

"dSLIM is a DNA molecule consisting of 80-120 nucleotides," CEO Burghardt Wittig told BioCentury. "dSLIM has two loop-like structures at either end of the molecule - think about a dumbbell. In the loops are single-stranded DNA sequence motifs that are recognized by human cells as bacterial." As a result, cells...

Read the full 454 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >